arctic peptide tirzepatide Europe | EU Research Tirzepatide | Healthy Aminos
Description
Appetite suppression becomes noticeable within days for most users
doi: 10.1186/S13643-016-0384-4/FIGURES/6
Conversely, initial studies comparing tirzepatide vs retatrutide have shown that retatrutide has demonstrated even more promising outcomes, with participants losing an average of 24.2% of their body mass after 48 weeks
Potential implications for future treatments The findings raise the possibility that GLP-1 drugs could eventually be modified or combined with other therapies to extend their effectiveness and reduce the frequency of dosing
doi: 10.1016/0092-8674(95)90013-6 54 BacchettaRBarzaghiFRoncaroloMG
